fanta.bio Sample: CNhs11846
20969 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| CTNNB1 SRX13991431 | MCF 10A Breast | 551 / 21515 (2.6%) | 209 / 215150 (0.1%) | −324.0 | −324.0 | 26.36 |
| SCML2 SRX644728 | 293 Kidney | 1880 / 21515 (8.7%) | 733 / 215150 (0.3%) | −324.0 | −324.0 | 25.65 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 2039 / 21515 (9.5%) | 850 / 215150 (0.4%) | −324.0 | −324.0 | 23.99 |
| FOXP1 SRX736067 | LNCAP Prostate | 2546 / 21515 (11.8%) | 1119 / 215150 (0.5%) | −324.0 | −324.0 | 22.75 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 2845 / 21515 (13.2%) | 1276 / 215150 (0.6%) | −324.0 | −324.0 | 22.30 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 2750 / 21515 (12.8%) | 1258 / 215150 (0.6%) | −324.0 | −324.0 | 21.86 |
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1134 / 21515 (5.3%) | 576 / 215150 (0.3%) | −324.0 | −324.0 | 19.69 |
| HIF1A SRX11007095 | HK-2 Kidney | 2245 / 21515 (10.4%) | 1181 / 215150 (0.5%) | −324.0 | −324.0 | 19.01 |
| HIF1A SRX20663235 | HK-2 Kidney | 571 / 21515 (2.7%) | 322 / 215150 (0.1%) | −324.0 | −324.0 | 17.73 |
| MYH11 SRX265221 | ME-1 Blood | 1108 / 21515 (5.1%) | 678 / 215150 (0.3%) | −324.0 | −324.0 | 16.34 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1626 / 21515 (7.6%) | 1032 / 215150 (0.5%) | −324.0 | −324.0 | 15.76 |
| MED1 SRX9419945 | BT-474 Breast | 3853 / 21515 (17.9%) | 3539 / 215150 (1.6%) | −324.0 | −324.0 | 10.89 |
| MED1 SRX9419944 | BT-474 Breast | 3790 / 21515 (17.6%) | 3484 / 215150 (1.6%) | −324.0 | −324.0 | 10.88 |
| BRD4 SRX9419938 | BT-474 Breast | 3915 / 21515 (18.2%) | 3698 / 215150 (1.7%) | −324.0 | −324.0 | 10.59 |
| BRD4 SRX9419936 | BT-474 Breast | 3932 / 21515 (18.3%) | 3752 / 215150 (1.7%) | −324.0 | −324.0 | 10.48 |
| MED1 SRX9419946 | BT-474 Breast | 3932 / 21515 (18.3%) | 3756 / 215150 (1.7%) | −324.0 | −324.0 | 10.47 |
| MED1 SRX9419947 | BT-474 Breast | 3826 / 21515 (17.8%) | 3666 / 215150 (1.7%) | −324.0 | −324.0 | 10.44 |
| BRD4 SRX9419935 | BT-474 Breast | 3747 / 21515 (17.4%) | 3594 / 215150 (1.7%) | −324.0 | −324.0 | 10.43 |
| BRD4 SRX9419937 | BT-474 Breast | 3764 / 21515 (17.5%) | 3638 / 215150 (1.7%) | −324.0 | −324.0 | 10.35 |
| EZH2 SRX2146136 | LNCAP Prostate | 9485 / 21515 (44.1%) | 9615 / 215150 (4.5%) | −324.0 | −324.0 | 9.86 |
| BRD4 SRX736201 | 90-8TL Neural | 6417 / 21515 (29.8%) | 8410 / 215150 (3.9%) | −324.0 | −324.0 | 7.63 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 2168 / 21515 (10.1%) | 3277 / 215150 (1.5%) | −324.0 | −324.0 | 6.62 |
| RELA SRX2207673 | HUVEC Cardiovascular | 1387 / 21515 (6.4%) | 32897 / 215150 (15.3%) | −324.0 | −324.0 | 0.42 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 1199 / 21515 (5.6%) | 30262 / 215150 (14.1%) | −324.0 | −324.0 | 0.40 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 1188 / 21515 (5.5%) | 31502 / 215150 (14.6%) | −324.0 | −324.0 | 0.38 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 1172 / 21515 (5.4%) | 31256 / 215150 (14.5%) | −324.0 | −324.0 | 0.37 |
| SS18 SRX3468047 | Fibroblasts Others | 916 / 21515 (4.3%) | 26066 / 215150 (12.1%) | −324.0 | −324.0 | 0.35 |
| AR SRX1067070 | LHSAR Prostate | 853 / 21515 (4.0%) | 25476 / 215150 (11.8%) | −324.0 | −324.0 | 0.33 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 828 / 21515 (3.8%) | 25156 / 215150 (11.7%) | −324.0 | −324.0 | 0.33 |
| PBX4 SRX2731658 | PC-3 Prostate | 1054 / 21515 (4.9%) | 34297 / 215150 (15.9%) | −324.0 | −324.0 | 0.31 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 693 / 21515 (3.2%) | 23361 / 215150 (10.9%) | −324.0 | −324.0 | 0.30 |
| JUNB SRX8488073 | SUM 229PE Breast | 618 / 21515 (2.9%) | 21706 / 215150 (10.1%) | −324.0 | −324.0 | 0.28 |
| AR SRX1067071 | LHSAR Prostate | 634 / 21515 (2.9%) | 22374 / 215150 (10.4%) | −324.0 | −324.0 | 0.28 |
| JUNB SRX8488088 | SUM 229PE Breast | 623 / 21515 (2.9%) | 22245 / 215150 (10.3%) | −324.0 | −324.0 | 0.28 |
| FOS SRX150478 | MCF 10A Breast | 684 / 21515 (3.2%) | 26301 / 215150 (12.2%) | −324.0 | −324.0 | 0.26 |
| FOS SRX150517 | MCF 10A Breast | 528 / 21515 (2.5%) | 20828 / 215150 (9.7%) | −324.0 | −324.0 | 0.25 |
| FOS SRX150477 | MCF 10A Breast | 638 / 21515 (3.0%) | 25643 / 215150 (11.9%) | −324.0 | −324.0 | 0.25 |
| JUN SRX17561461 | LPS141 Adipocyte | 460 / 21515 (2.1%) | 18686 / 215150 (8.7%) | −324.0 | −324.0 | 0.25 |
| YAP1 SRX757325 | H2052 Lung | 627 / 21515 (2.9%) | 26565 / 215150 (12.3%) | −324.0 | −324.0 | 0.24 |
| FOS SRX4192880 | MCF 10A Breast | 490 / 21515 (2.3%) | 20918 / 215150 (9.7%) | −324.0 | −324.0 | 0.23 |
| YAP1 SRX757326 | H2052 Lung | 528 / 21515 (2.5%) | 23772 / 215150 (11.0%) | −324.0 | −324.0 | 0.22 |
| FOS SRX150476 | MCF 10A Breast | 605 / 21515 (2.8%) | 20853 / 215150 (9.7%) | −319.6 | −316.7 | 0.29 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 298 / 21515 (1.4%) | 15268 / 215150 (7.1%) | −318.1 | −315.2 | 0.20 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 807 / 21515 (3.8%) | 24083 / 215150 (11.2%) | −317.9 | −315.0 | 0.34 |
| KAT7 SRX101303 | RKO Digestive tract | 1878 / 21515 (8.7%) | 6367 / 215150 (3.0%) | −314.6 | −311.7 | 2.95 |
| SMARCA4 SRX5212362 | Mel270 Others | 604 / 21515 (2.8%) | 20588 / 215150 (9.6%) | −311.7 | −308.8 | 0.29 |
| ESR1 SRX176860 | MCF-7 Breast | 582 / 21515 (2.7%) | 20216 / 215150 (9.4%) | −311.7 | −308.8 | 0.29 |
| FOS SRX4192879 | MCF 10A Breast | 367 / 21515 (1.7%) | 16382 / 215150 (7.6%) | −310.7 | −307.8 | 0.22 |
| SMARCA2 SRX8119677 | MeT-5A Others | 567 / 21515 (2.6%) | 19924 / 215150 (9.3%) | −310.4 | −307.6 | 0.28 |
| RELA SRX2207672 | HUVEC Cardiovascular | 1532 / 21515 (7.1%) | 34423 / 215150 (16.0%) | −309.6 | −306.8 | 0.45 |
| GATA3 SRX190194 | SK-N-SH Neural | 876 / 21515 (4.1%) | 24880 / 215150 (11.6%) | −309.5 | −306.7 | 0.35 |
| ESR1 SRX4367193 | MCF-7 Breast | 1253 / 21515 (5.8%) | 30433 / 215150 (14.1%) | −308.0 | −305.2 | 0.41 |
| ESR1 SRX176861 | MCF-7 Breast | 591 / 21515 (2.7%) | 20244 / 215150 (9.4%) | −307.7 | −304.9 | 0.29 |
| MAU2 SRX15710550 | Fibroblasts Others | 574 / 21515 (2.7%) | 19953 / 215150 (9.3%) | −307.5 | −304.7 | 0.29 |
| SMARCA4 SRX5212366 | Mel270 Others | 449 / 21515 (2.1%) | 17762 / 215150 (8.3%) | −306.8 | −304.0 | 0.25 |
| SMARCA4 SRX5212357 | Mel270 Others | 495 / 21515 (2.3%) | 18542 / 215150 (8.6%) | −305.8 | −303.0 | 0.27 |
| JUNB SRX8488074 | SUM 229PE Breast | 443 / 21515 (2.1%) | 17621 / 215150 (8.2%) | −305.6 | −302.8 | 0.25 |
| MEAF6 DRX300417 | 293 Kidney | 2160 / 21515 (10.0%) | 8193 / 215150 (3.8%) | −305.1 | −302.4 | 2.64 |
| SMARCA4 SRX5212371 | Mel270 Others | 481 / 21515 (2.2%) | 18245 / 215150 (8.5%) | −303.9 | −301.2 | 0.26 |
| ESR1 SRX371478 | MCF-7 Breast | 452 / 21515 (2.1%) | 17711 / 215150 (8.2%) | −303.2 | −300.5 | 0.26 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 618 / 21515 (2.9%) | 20535 / 215150 (9.5%) | −302.6 | −299.9 | 0.30 |
| Epitope tags DRX443510 | 293 Kidney | 2044 / 21515 (9.5%) | 7559 / 215150 (3.5%) | −300.2 | −297.5 | 2.70 |
| MEAF6 DRX234811 | 293 Kidney | 2322 / 21515 (10.8%) | 9288 / 215150 (4.3%) | −300.2 | −297.5 | 2.50 |
| TP53 SRX19538279 | Osteoblasts Bone | 520 / 21515 (2.4%) | 365 / 215150 (0.2%) | −299.8 | −297.1 | 14.25 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 1120 / 21515 (5.2%) | 28193 / 215150 (13.1%) | −299.3 | −296.6 | 0.40 |
| JUN SRX883584 | MDA-MB-231 Breast | 558 / 21515 (2.6%) | 19415 / 215150 (9.0%) | −299.0 | −296.3 | 0.29 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 282 / 21515 (1.3%) | 14388 / 215150 (6.7%) | −298.1 | −295.5 | 0.20 |
| TCF12 SRX190356 | SK-N-SH Neural | 1056 / 21515 (4.9%) | 27199 / 215150 (12.6%) | −297.9 | −295.2 | 0.39 |
| Epitope tags SRX10549776 | K-562 Blood | 1859 / 21515 (8.6%) | 6503 / 215150 (3.0%) | −296.9 | −294.3 | 2.86 |
| SMARCC1 SRX11379505 | Liposarcoma, Myxoid Adipocyte | 639 / 21515 (3.0%) | 20669 / 215150 (9.6%) | −296.1 | −293.4 | 0.31 |
| SMARCC1 SRX11379504 | Liposarcoma, Myxoid Adipocyte | 1144 / 21515 (5.3%) | 28366 / 215150 (13.2%) | −294.3 | −291.7 | 0.40 |
| SMARCC1 SRX11379506 | Liposarcoma, Myxoid Adipocyte | 624 / 21515 (2.9%) | 20367 / 215150 (9.5%) | −294.2 | −291.6 | 0.31 |
| NR3C1 SRX2609664 | HASM2 Lung | 496 / 21515 (2.3%) | 18165 / 215150 (8.4%) | −292.8 | −290.2 | 0.27 |
| ESR1 SRX7624157 | MCF-7 Breast | 1025 / 21515 (4.8%) | 26548 / 215150 (12.3%) | −292.5 | −289.8 | 0.39 |
| ESR1 SRX7624156 | MCF-7 Breast | 598 / 21515 (2.8%) | 19857 / 215150 (9.2%) | −291.8 | −289.1 | 0.30 |
| ESR1 SRX20282961 | MCF-7 Breast | 461 / 21515 (2.1%) | 17513 / 215150 (8.1%) | −291.5 | −288.8 | 0.26 |
| BRD1 SRX286203 | RKO Digestive tract | 1597 / 21515 (7.4%) | 5113 / 215150 (2.4%) | −288.6 | −286.0 | 3.12 |
| TP53 SRX19538274 | U2OS Bone | 437 / 21515 (2.0%) | 213 / 215150 (0.1%) | −288.4 | −285.8 | 20.52 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 744 / 21515 (3.5%) | 22085 / 215150 (10.3%) | −287.6 | −285.0 | 0.34 |
| JUN SRX6582171 | GM07492 Others | 739 / 21515 (3.4%) | 21990 / 215150 (10.2%) | −287.2 | −284.6 | 0.34 |
| YAP1 SRX5718140 | 293 Kidney | 638 / 21515 (3.0%) | 20364 / 215150 (9.5%) | −287.0 | −284.4 | 0.31 |
| AR SRX10820653 | LNCAP Prostate | 431 / 21515 (2.0%) | 207 / 215150 (0.1%) | −285.8 | −283.2 | 20.82 |
| JUNB SRX10119386 | MCF 10A Breast | 295 / 21515 (1.4%) | 14210 / 215150 (6.6%) | −283.1 | −280.5 | 0.21 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 432 / 21515 (2.0%) | 16727 / 215150 (7.8%) | −282.6 | −280.0 | 0.26 |
| ESR1 SRX371479 | MCF-7 Breast | 323 / 21515 (1.5%) | 14733 / 215150 (6.8%) | −282.5 | −279.9 | 0.22 |
| ESR1 SRX371469 | MCF-7 Breast | 381 / 21515 (1.8%) | 15758 / 215150 (7.3%) | −280.8 | −278.2 | 0.24 |
| ESR1 SRX20282960 | MCF-7 Breast | 420 / 21515 (2.0%) | 16452 / 215150 (7.6%) | −280.4 | −277.9 | 0.26 |
| BRPF3 SRX796084 | RKO Digestive tract | 2009 / 21515 (9.3%) | 7683 / 215150 (3.6%) | −278.8 | −276.2 | 2.61 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 435 / 21515 (2.0%) | 16664 / 215150 (7.7%) | −278.8 | −276.2 | 0.26 |
| NR3C1 SRX2609659 | HASM2 Lung | 417 / 21515 (1.9%) | 16333 / 215150 (7.6%) | −278.3 | −275.8 | 0.26 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 469 / 21515 (2.2%) | 17241 / 215150 (8.0%) | −278.1 | −275.6 | 0.27 |
| FOXA1 SRX176862 | MCF-7 Breast | 509 / 21515 (2.4%) | 17912 / 215150 (8.3%) | −277.5 | −275.0 | 0.28 |
| JUNB SRX4192882 | MCF 10A Breast | 256 / 21515 (1.2%) | 13189 / 215150 (6.1%) | −274.0 | −271.5 | 0.19 |
| JUN SRX4192884 | MCF 10A Breast | 274 / 21515 (1.3%) | 13538 / 215150 (6.3%) | −273.8 | −271.2 | 0.20 |
| ESR1 SRX20282939 | MCF-7 Breast | 431 / 21515 (2.0%) | 16438 / 215150 (7.6%) | −273.7 | −271.1 | 0.26 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 766 / 21515 (3.6%) | 21947 / 215150 (10.2%) | −273.3 | −270.7 | 0.35 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1484 / 21515 (6.9%) | 4688 / 215150 (2.2%) | −272.6 | −270.0 | 3.17 |
| JUN SRX6582172 | Fibroblasts Others | 495 / 21515 (2.3%) | 17495 / 215150 (8.1%) | −271.9 | −269.4 | 0.28 |
| JUNB SRX8488089 | SUM 229PE Breast | 355 / 21515 (1.7%) | 15009 / 215150 (7.0%) | −271.6 | −269.1 | 0.24 |
| SMARCC1 SRX11379511 | Liposarcoma, Myxoid Adipocyte | 504 / 21515 (2.3%) | 17636 / 215150 (8.2%) | −271.5 | −268.9 | 0.29 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 984 / 21515 (4.6%) | 25194 / 215150 (11.7%) | −271.4 | −268.9 | 0.39 |
| FOXA1 SRX176863 | MCF-7 Breast | 474 / 21515 (2.2%) | 17099 / 215150 (7.9%) | −270.7 | −268.2 | 0.28 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 783 / 21515 (3.6%) | 22089 / 215150 (10.3%) | −269.7 | −267.2 | 0.35 |
| NR3C1 SRX2609662 | HASM2 Lung | 441 / 21515 (2.0%) | 16494 / 215150 (7.7%) | −269.7 | −267.2 | 0.27 |
| TP53 SRX19538268 | U2OS Bone | 425 / 21515 (2.0%) | 236 / 215150 (0.1%) | −268.2 | −265.7 | 18.01 |
| FOSL2 SRX190296 | SK-N-SH Neural | 507 / 21515 (2.4%) | 17550 / 215150 (8.2%) | −267.3 | −264.8 | 0.29 |
| ESR1 SRX20282954 | MCF-7 Breast | 413 / 21515 (1.9%) | 15921 / 215150 (7.4%) | −267.2 | −264.7 | 0.26 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 579 / 21515 (2.7%) | 18708 / 215150 (8.7%) | −265.9 | −263.4 | 0.31 |
| NR3C1 SRX2609661 | HASM2 Lung | 411 / 21515 (1.9%) | 15816 / 215150 (7.4%) | −265.0 | −262.5 | 0.26 |
| FOSL2 SRX3367141 | SK-MEL-147 Epidermis | 547 / 21515 (2.5%) | 18127 / 215150 (8.4%) | −264.3 | −261.8 | 0.30 |
| EP300 SRX2671813 | Fibroblasts Others | 290 / 21515 (1.3%) | 13565 / 215150 (6.3%) | −264.0 | −261.5 | 0.21 |
| BRPF3 SRX796086 | RKO Digestive tract | 1903 / 21515 (8.8%) | 7282 / 215150 (3.4%) | −262.9 | −260.5 | 2.61 |
| NR3C1 SRX2609665 | HASM2 Lung | 414 / 21515 (1.9%) | 15791 / 215150 (7.3%) | −262.4 | −260.0 | 0.26 |
| LEO1 SRX1873456 | SEM Blood | 1939 / 21515 (9.0%) | 7528 / 215150 (3.5%) | −261.6 | −259.1 | 2.58 |
| JUNB SRX10119383 | MCF 10A Breast | 224 / 21515 (1.0%) | 12159 / 215150 (5.7%) | −260.5 | −258.0 | 0.18 |
| VGLL1 SRX24602130 | BT-20 Breast | 391 / 21515 (1.8%) | 15321 / 215150 (7.1%) | −260.3 | −257.9 | 0.26 |
| DAXX SRX1021630 | PC-3 Prostate | 369 / 21515 (1.7%) | 14895 / 215150 (6.9%) | −259.3 | −256.9 | 0.25 |
| ESR1 SRX20282972 | MCF-7 Breast | 441 / 21515 (2.0%) | 16124 / 215150 (7.5%) | −257.9 | −255.5 | 0.27 |
| EP300 SRX2194266 | SUM 159PT Breast | 699 / 21515 (3.2%) | 20360 / 215150 (9.5%) | −257.4 | −254.9 | 0.34 |
| ESR1 SRX1531791 | MCF-7 Breast | 375 / 21515 (1.7%) | 14942 / 215150 (6.9%) | −257.3 | −254.9 | 0.25 |
| BRPF3 SRX796085 | RKO Digestive tract | 1410 / 21515 (6.6%) | 4480 / 215150 (2.1%) | −256.5 | −254.1 | 3.15 |
| EP300 SRX2194265 | SUM 159PT Breast | 628 / 21515 (2.9%) | 19183 / 215150 (8.9%) | −256.1 | −253.7 | 0.33 |
| TP53 SRX19538267 | U2OS Bone | 392 / 21515 (1.8%) | 198 / 215150 (0.1%) | −255.6 | −253.2 | 19.80 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 528 / 21515 (2.5%) | 17517 / 215150 (8.1%) | −255.1 | −252.7 | 0.30 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 994 / 21515 (4.6%) | 24733 / 215150 (11.5%) | −254.7 | −252.3 | 0.40 |
| FOSL2 SRX5054309 | Neural progenitor cells Neural | 382 / 21515 (1.8%) | 14985 / 215150 (7.0%) | −254.6 | −252.2 | 0.25 |
| ESR1 SRX10365535 | MCF-7 Breast | 296 / 21515 (1.4%) | 13396 / 215150 (6.2%) | −254.4 | −252.0 | 0.22 |
| ESR1 SRX194569 | MCF-7 Breast | 418 / 21515 (1.9%) | 15594 / 215150 (7.2%) | −253.7 | −251.3 | 0.27 |
| ESR1 SRX4367192 | MCF-7 Breast | 853 / 21515 (4.0%) | 22598 / 215150 (10.5%) | −253.5 | −251.1 | 0.38 |
| JUND SRX190357 | SK-N-SH Neural | 499 / 21515 (2.3%) | 16945 / 215150 (7.9%) | −252.5 | −250.1 | 0.29 |
| ESR1 SRX371467 | MCF-7 Breast | 421 / 21515 (2.0%) | 15608 / 215150 (7.3%) | −252.5 | −250.1 | 0.27 |
| FOXA1 SRX371481 | MCF-7 Breast | 433 / 21515 (2.0%) | 15813 / 215150 (7.3%) | −252.5 | −250.1 | 0.27 |
| FOXA1 SRX4815198 | MCF-7 Breast | 1454 / 21515 (6.8%) | 31125 / 215150 (14.5%) | −251.9 | −249.5 | 0.47 |
| TP53 SRX19538276 | U2OS Bone | 406 / 21515 (1.9%) | 242 / 215150 (0.1%) | −249.7 | −247.3 | 16.78 |
| SMARCC1 SRX11379517 | Liposarcoma, Myxoid Adipocyte | 311 / 21515 (1.4%) | 13500 / 215150 (6.3%) | −248.4 | −246.0 | 0.23 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 712 / 21515 (3.3%) | 1201 / 215150 (0.6%) | −247.7 | −245.3 | 5.93 |
| AR SRX10820651 | LNCAP Prostate | 446 / 21515 (2.1%) | 342 / 215150 (0.2%) | −247.5 | −245.1 | 13.04 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 726 / 21515 (3.4%) | 20432 / 215150 (9.5%) | −247.2 | −244.8 | 0.36 |
| GATA3 SRX190239 | MCF-7 Breast | 628 / 21515 (2.9%) | 18888 / 215150 (8.8%) | −247.2 | −244.8 | 0.33 |
| ESR1 SRX20282973 | MCF-7 Breast | 494 / 21515 (2.3%) | 16678 / 215150 (7.8%) | −246.8 | −244.5 | 0.30 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 1190 / 21515 (5.5%) | 3420 / 215150 (1.6%) | −246.0 | −243.6 | 3.48 |
| BMI1 SRX644729 | 293 Kidney | 339 / 21515 (1.6%) | 120 / 215150 (0.1%) | −245.8 | −243.4 | 28.25 |
| YAP1 SRX10119364 | MCF 10A Breast | 313 / 21515 (1.5%) | 13452 / 215150 (6.3%) | −245.5 | −243.1 | 0.23 |
| SS18 SRX10640841 | SK-MEL-147 Epidermis | 590 / 21515 (2.7%) | 18212 / 215150 (8.5%) | −245.4 | −243.0 | 0.32 |
| NR3C1 SRX2609666 | HASM2 Lung | 373 / 21515 (1.7%) | 14532 / 215150 (6.8%) | −245.2 | −242.8 | 0.26 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 708 / 21515 (3.3%) | 1202 / 215150 (0.6%) | −245.0 | −242.7 | 5.89 |
| FOSL2 SRX10640867 | SK-MEL-147 Epidermis | 739 / 21515 (3.4%) | 20546 / 215150 (9.5%) | −244.7 | −242.3 | 0.36 |
| SMARCA4 SRX8588624 | Pulmonary artery endothelial cells Cardiovascular | 744 / 21515 (3.5%) | 20620 / 215150 (9.6%) | −244.6 | −242.2 | 0.36 |
| FOXA1 SRX1161177 | MCF-7 Breast | 427 / 21515 (2.0%) | 15458 / 215150 (7.2%) | −244.4 | −242.1 | 0.28 |
| FOXA1 SRX4815197 | MCF-7 Breast | 1071 / 21515 (5.0%) | 25450 / 215150 (11.8%) | −243.8 | −241.5 | 0.42 |
| EP300 SRX2671792 | Cardiac progenitor cells Cardiovascular | 274 / 21515 (1.3%) | 12666 / 215150 (5.9%) | −243.8 | −241.5 | 0.22 |
| JUNB SRX10119384 | MCF 10A Breast | 209 / 21515 (1.0%) | 11369 / 215150 (5.3%) | −243.4 | −241.0 | 0.18 |
| ING5 SRX286202 | RKO Digestive tract | 1714 / 21515 (8.0%) | 6444 / 215150 (3.0%) | −242.9 | −240.6 | 2.66 |
| TP53 SRX19538280 | Osteoblasts Bone | 412 / 21515 (1.9%) | 274 / 215150 (0.1%) | −242.8 | −240.5 | 15.04 |
| JUN SRX7277180 | GM07492 Others | 314 / 21515 (1.5%) | 13390 / 215150 (6.2%) | −242.8 | −240.5 | 0.23 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 439 / 21515 (2.0%) | 15575 / 215150 (7.2%) | −241.6 | −239.3 | 0.28 |
| ESR1 SRX371476 | MCF-7 Breast | 298 / 21515 (1.4%) | 13039 / 215150 (6.1%) | −241.1 | −238.8 | 0.23 |
| SS18 SRX10640842 | SK-MEL-147 Epidermis | 536 / 21515 (2.5%) | 17189 / 215150 (8.0%) | −241.0 | −238.7 | 0.31 |
| FOS SRX070879 | HUVEC Cardiovascular | 428 / 21515 (2.0%) | 15362 / 215150 (7.1%) | −240.8 | −238.5 | 0.28 |
| EP300 SRX150579 | HeLa Uterus | 236 / 21515 (1.1%) | 11831 / 215150 (5.5%) | −240.4 | −238.1 | 0.20 |
| WWTR1 SRX10119367 | MCF 10A Breast | 478 / 21515 (2.2%) | 16147 / 215150 (7.5%) | −238.7 | −236.4 | 0.30 |
| JADE3 DRX300415 | 293 Kidney | 1990 / 21515 (9.2%) | 8254 / 215150 (3.8%) | −238.5 | −236.2 | 2.41 |
| SMARCA4 SRX5075175 | Neural progenitor cells Neural | 632 / 21515 (2.9%) | 18637 / 215150 (8.7%) | −237.9 | −235.6 | 0.34 |
| ESR1 SRX371468 | MCF-7 Breast | 250 / 21515 (1.2%) | 12018 / 215150 (5.6%) | −237.6 | −235.3 | 0.21 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 382 / 21515 (1.8%) | 14453 / 215150 (6.7%) | −237.4 | −235.1 | 0.26 |
| YAP1 SRX10119388 | MDA-MB-231 Breast | 256 / 21515 (1.2%) | 12126 / 215150 (5.6%) | −237.3 | −235.0 | 0.21 |
| AR SRX1067067 | LHSAR Prostate | 731 / 21515 (3.4%) | 20161 / 215150 (9.4%) | −237.3 | −235.0 | 0.36 |
| ESR1 SRX330067 | MCF-7 Breast | 361 / 21515 (1.7%) | 14066 / 215150 (6.5%) | −237.0 | −234.7 | 0.26 |
| ESR1 SRX20282940 | MCF-7 Breast | 455 / 21515 (2.1%) | 15701 / 215150 (7.3%) | −236.9 | −234.7 | 0.29 |
| JUN SRX2355072 | HAEC Cardiovascular | 554 / 21515 (2.6%) | 17342 / 215150 (8.1%) | −236.7 | −234.5 | 0.32 |
| JUN SRX9350646 | Melanoma cell line Epidermis | 561 / 21515 (2.6%) | 17442 / 215150 (8.1%) | −236.4 | −234.1 | 0.32 |
| JUND SRX150408 | HeLa Uterus | 350 / 21515 (1.6%) | 13846 / 215150 (6.4%) | −236.3 | −234.0 | 0.25 |
| ESR1 SRX10365536 | MCF-7 Breast | 194 / 21515 (0.9%) | 10864 / 215150 (5.0%) | −236.2 | −234.0 | 0.18 |
| PRRX1 SRX15235713 | Hs 578T Breast | 516 / 21515 (2.4%) | 16689 / 215150 (7.8%) | −235.8 | −233.5 | 0.31 |
| FOSL2 SRX10640864 | SK-MEL-147 Epidermis | 571 / 21515 (2.7%) | 17581 / 215150 (8.2%) | −235.5 | −233.3 | 0.32 |
| FOS SRX150664 | HUVEC Cardiovascular | 561 / 21515 (2.6%) | 17415 / 215150 (8.1%) | −235.5 | −233.3 | 0.32 |
| GATA3 SRX176864 | MCF-7 Breast | 298 / 21515 (1.4%) | 12866 / 215150 (6.0%) | −235.3 | −233.0 | 0.23 |
| PBX3 SRX190343 | SK-N-SH Neural | 916 / 21515 (4.3%) | 22868 / 215150 (10.6%) | −235.1 | −232.8 | 0.40 |
| ESR1 SRX371470 | ZR-75-1 Breast | 384 / 21515 (1.8%) | 14407 / 215150 (6.7%) | −234.8 | −232.5 | 0.27 |
| ESR1 SRX194572 | MCF-7 Breast | 251 / 21515 (1.2%) | 11953 / 215150 (5.6%) | −234.7 | −232.4 | 0.21 |
| AGO2 SRX4708039 | Hep G2 Liver | 2170 / 21515 (10.1%) | 9511 / 215150 (4.4%) | −234.6 | −232.3 | 2.28 |
| JUN SRX6582163 | BJ-5ta Epidermis | 532 / 21515 (2.5%) | 16895 / 215150 (7.9%) | −234.1 | −231.8 | 0.31 |
| FOXA1 SRX371482 | MCF-7 Breast | 646 / 21515 (3.0%) | 18723 / 215150 (8.7%) | −234.0 | −231.8 | 0.35 |
| TP53 SRX19538273 | U2OS Bone | 368 / 21515 (1.7%) | 200 / 215150 (0.1%) | −234.0 | −231.8 | 18.40 |
| ESR1 SRX20282955 | MCF-7 Breast | 448 / 21515 (2.1%) | 15461 / 215150 (7.2%) | −233.1 | −230.8 | 0.29 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 379 / 21515 (1.8%) | 14242 / 215150 (6.6%) | −232.4 | −230.1 | 0.27 |
| TP53 SRX19538275 | U2OS Bone | 380 / 21515 (1.8%) | 230 / 215150 (0.1%) | −232.3 | −230.1 | 16.52 |
| ESR1 SRX371471 | ZR-75-1 Breast | 473 / 21515 (2.2%) | 15841 / 215150 (7.4%) | −231.8 | −229.5 | 0.30 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 373 / 21515 (1.7%) | 14120 / 215150 (6.6%) | −231.7 | −229.5 | 0.26 |
| STAT3 SRX150479 | MCF 10A Breast | 381 / 21515 (1.8%) | 14233 / 215150 (6.6%) | −230.9 | −228.7 | 0.27 |
| KAT7 DRX234808 | 293 Kidney | 1034 / 21515 (4.8%) | 2783 / 215150 (1.3%) | −230.7 | −228.5 | 3.72 |
| FOXA1 SRX371483 | MCF-7 Breast | 508 / 21515 (2.4%) | 16388 / 215150 (7.6%) | −230.7 | −228.5 | 0.31 |
| NR3C1 SRX10976921 | A549 Lung | 275 / 21515 (1.3%) | 12281 / 215150 (5.7%) | −230.1 | −227.9 | 0.22 |
| MAML1 SRX8970969 | Squamous cell carcinoma Others | 402 / 21515 (1.9%) | 14571 / 215150 (6.8%) | −230.0 | −227.7 | 0.28 |
| SS18 SRX10640843 | SK-MEL-147 Epidermis | 685 / 21515 (3.2%) | 19183 / 215150 (8.9%) | −229.6 | −227.4 | 0.36 |
| STAT3 SRX150630 | MCF 10A Breast | 381 / 21515 (1.8%) | 14153 / 215150 (6.6%) | −228.4 | −226.2 | 0.27 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 1071 / 21515 (5.0%) | 2997 / 215150 (1.4%) | −228.3 | −226.0 | 3.57 |
| TAL1 SRX393518 | Primary endothelial cells Cardiovascular | 623 / 21515 (2.9%) | 18161 / 215150 (8.4%) | −228.1 | −225.9 | 0.34 |
| JUN SRX6582165 | BJ-5ta Epidermis | 855 / 21515 (4.0%) | 21707 / 215150 (10.1%) | −228.0 | −225.8 | 0.39 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 645 / 21515 (3.0%) | 18482 / 215150 (8.6%) | −227.4 | −225.2 | 0.35 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 1024 / 21515 (4.8%) | 24142 / 215150 (11.2%) | −227.1 | −224.9 | 0.42 |
| GATA3 SRX5057632 | MCF-7 Breast | 268 / 21515 (1.2%) | 12044 / 215150 (5.6%) | −226.6 | −224.3 | 0.22 |
| TAZ SRX14181208 | MSK-PCa3 Prostate | 449 / 21515 (2.1%) | 15259 / 215150 (7.1%) | −226.4 | −224.2 | 0.29 |
| TP53 SRX2585782 | MDA-MB-231 Breast | 820 / 21515 (3.8%) | 21124 / 215150 (9.8%) | −226.4 | −224.2 | 0.39 |
| NR3C1 SRX8520809 | SUM 159PT Breast | 358 / 21515 (1.7%) | 13671 / 215150 (6.4%) | −226.0 | −223.8 | 0.26 |
| TLE3 SRX4815194 | SUM 149PT Breast | 309 / 21515 (1.4%) | 12773 / 215150 (5.9%) | −225.5 | −223.3 | 0.24 |
| CEBPB SRX150632 | HeLa Uterus | 1024 / 21515 (4.8%) | 24076 / 215150 (11.2%) | −225.3 | −223.1 | 0.43 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 326 / 21515 (1.5%) | 13079 / 215150 (6.1%) | −225.3 | −223.1 | 0.25 |
| FOXA1 SRX371480 | MCF-7 Breast | 285 / 21515 (1.3%) | 12306 / 215150 (5.7%) | −224.7 | −222.5 | 0.23 |
| FOXA1 SRX1161173 | MCF-7 Breast | 351 / 21515 (1.6%) | 13480 / 215150 (6.3%) | −223.8 | −221.7 | 0.26 |
| SMAD3 SRX366168 | NCI-H441 Lung | 359 / 21515 (1.7%) | 13620 / 215150 (6.3%) | −223.7 | −221.5 | 0.26 |
| YAP1 SRX10119387 | MDA-MB-231 Breast | 292 / 21515 (1.4%) | 12402 / 215150 (5.8%) | −223.6 | −221.4 | 0.24 |
| FOXA1 SRX1161176 | MCF-7 Breast | 431 / 21515 (2.0%) | 14863 / 215150 (6.9%) | −223.5 | −221.3 | 0.29 |
| WWTR1 SRX10119378 | MCF 10A Breast | 460 / 21515 (2.1%) | 15346 / 215150 (7.1%) | −223.4 | −221.2 | 0.30 |
| ATF1 SRX11470446 | Mesenchymal stem cells Others | 1138 / 21515 (5.3%) | 25576 / 215150 (11.9%) | −222.3 | −220.1 | 0.44 |
| TP53 SRX19538281 | Osteoblasts Bone | 433 / 21515 (2.0%) | 392 / 215150 (0.2%) | −222.2 | −220.0 | 11.05 |
| RAC1 SRX10365543 | MCF-7 Breast | 213 / 21515 (1.0%) | 10822 / 215150 (5.0%) | −221.4 | −219.2 | 0.20 |
| ESR1 SRX330069 | MCF-7 Breast | 243 / 21515 (1.1%) | 11403 / 215150 (5.3%) | −221.2 | −219.0 | 0.21 |
| NR3C1 SRX9298951 | Lung cancer cell line Lung | 254 / 21515 (1.2%) | 11614 / 215150 (5.4%) | −221.0 | −218.9 | 0.22 |
| KDM1A SRX10637290 | MDA-MB-231 Breast | 571 / 21515 (2.7%) | 17078 / 215150 (7.9%) | −220.7 | −218.6 | 0.33 |
| JADE3 DRX234809 | 293 Kidney | 1334 / 21515 (6.2%) | 4534 / 215150 (2.1%) | −219.9 | −217.8 | 2.94 |
| RELA SRX5938177 | FaDu Others | 391 / 21515 (1.8%) | 14059 / 215150 (6.5%) | −219.9 | −217.7 | 0.28 |
| RAC1 SRX10365541 | MCF-7 Breast | 218 / 21515 (1.0%) | 10878 / 215150 (5.1%) | −219.9 | −217.7 | 0.20 |
| YAP1 SRX1038945 | IMR-90 Lung | 313 / 21515 (1.5%) | 12673 / 215150 (5.9%) | −219.8 | −217.7 | 0.25 |
| TEAD1 SRX14688734 | HUVEC Cardiovascular | 362 / 21515 (1.7%) | 13545 / 215150 (6.3%) | −219.6 | −217.4 | 0.27 |
| FOXA1 SRX1161175 | MCF-7 Breast | 331 / 21515 (1.5%) | 12990 / 215150 (6.0%) | −219.5 | −217.3 | 0.25 |
| ESR1 SRX20282971 | MCF-7 Breast | 435 / 21515 (2.0%) | 14789 / 215150 (6.9%) | −219.2 | −217.0 | 0.29 |
| ESR1 SRX2881002 | MCF-7 Breast | 412 / 21515 (1.9%) | 14395 / 215150 (6.7%) | −219.1 | −216.9 | 0.29 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 996 / 21515 (4.6%) | 2713 / 215150 (1.3%) | −219.0 | −216.8 | 3.67 |
| JUND SRX699738 | HCASMC Cardiovascular | 630 / 21515 (2.9%) | 17927 / 215150 (8.3%) | −218.3 | −216.1 | 0.35 |
| AR SRX1067066 | LHSAR Prostate | 971 / 21515 (4.5%) | 23034 / 215150 (10.7%) | −218.1 | −216.0 | 0.42 |
| ESR1 SRX2881000 | MCF-7 Breast | 379 / 21515 (1.8%) | 13785 / 215150 (6.4%) | −217.8 | −215.6 | 0.27 |
| NR3C1 SRX10977372 | A549 Lung | 230 / 21515 (1.1%) | 11045 / 215150 (5.1%) | −217.5 | −215.4 | 0.21 |
| FOXA2 SRX6441755 | CFPAC-1 Pancreas | 329 / 21515 (1.5%) | 12887 / 215150 (6.0%) | −217.3 | −215.2 | 0.26 |
| TLE3 SRX4815191 | MCF-7 Breast | 450 / 21515 (2.1%) | 14969 / 215150 (7.0%) | −216.9 | −214.8 | 0.30 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 354 / 21515 (1.6%) | 13314 / 215150 (6.2%) | −216.7 | −214.6 | 0.27 |
| EP300 SRX10976215 | A549 Lung | 403 / 21515 (1.9%) | 14120 / 215150 (6.6%) | −215.4 | −213.2 | 0.29 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 425 / 21515 (2.0%) | 14498 / 215150 (6.7%) | −215.3 | −213.2 | 0.29 |
| ARID1A SRX5089376 | MCF-7 Breast | 390 / 21515 (1.8%) | 13888 / 215150 (6.5%) | −215.0 | −212.8 | 0.28 |
| FOXA1 SRX3931044 | MCF-7 Breast | 1015 / 21515 (4.7%) | 23535 / 215150 (10.9%) | −214.7 | −212.5 | 0.43 |
| JUN SRX6582164 | BJ-5ta Epidermis | 574 / 21515 (2.7%) | 16920 / 215150 (7.9%) | −214.6 | −212.5 | 0.34 |
| SMARCA4 SRX8588623 | Pulmonary artery endothelial cells Cardiovascular | 646 / 21515 (3.0%) | 18036 / 215150 (8.4%) | −214.2 | −212.1 | 0.36 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 954 / 21515 (4.4%) | 2561 / 215150 (1.2%) | −213.3 | −211.1 | 3.73 |
| NR2F2 SRX190293 | MCF-7 Breast | 474 / 21515 (2.2%) | 15247 / 215150 (7.1%) | −213.2 | −211.1 | 0.31 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 450 / 21515 (2.1%) | 14840 / 215150 (6.9%) | −212.9 | −210.8 | 0.30 |
| Epitope tags SRX11470449 | Mesenchymal stem cells Others | 689 / 21515 (3.2%) | 18618 / 215150 (8.7%) | −211.8 | −209.7 | 0.37 |
| FOXA2 SRX6441754 | CFPAC-1 Pancreas | 323 / 21515 (1.5%) | 12593 / 215150 (5.9%) | −211.3 | −209.2 | 0.26 |
| ESR1 SRX10365532 | MCF-7 Breast | 228 / 21515 (1.1%) | 10816 / 215150 (5.0%) | −211.1 | −208.9 | 0.21 |
| SSRP1 SRX3436567 | HT-1080 Bone | 511 / 21515 (2.4%) | 677 / 215150 (0.3%) | −211.0 | −208.9 | 7.55 |
| SMC1A SRX1013334 | HuCCT1 Liver | 1338 / 21515 (6.2%) | 27874 / 215150 (13.0%) | −210.9 | −208.7 | 0.48 |
| NR3C1 SRX10977357 | A549 Lung | 261 / 21515 (1.2%) | 11435 / 215150 (5.3%) | −210.7 | −208.5 | 0.23 |
| FOSL2 SRX190204 | A549 Lung | 444 / 21515 (2.1%) | 14665 / 215150 (6.8%) | −210.6 | −208.5 | 0.30 |
| STAT3 SRX2020842 | HCC70 Breast | 821 / 21515 (3.8%) | 20562 / 215150 (9.6%) | −210.6 | −208.5 | 0.40 |
| ESR1 SRX20282953 | MCF-7 Breast | 365 / 21515 (1.7%) | 13296 / 215150 (6.2%) | −210.0 | −207.9 | 0.27 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 397 / 21515 (1.8%) | 13836 / 215150 (6.4%) | −209.6 | −207.5 | 0.29 |
| ESR1 SRX11120903 | MCF-7 Breast | 384 / 21515 (1.8%) | 13608 / 215150 (6.3%) | −209.6 | −207.4 | 0.28 |
| ESR1 SRX3110725 | MCF-7 Breast | 400 / 21515 (1.9%) | 13884 / 215150 (6.5%) | −209.5 | −207.4 | 0.29 |
| ESR1 SRX20282938 | MCF-7 Breast | 357 / 21515 (1.7%) | 13133 / 215150 (6.1%) | −209.4 | −207.3 | 0.27 |
| NR3C1 SRX17639412 | A549 Lung | 512 / 21515 (2.4%) | 15741 / 215150 (7.3%) | −209.4 | −207.3 | 0.33 |
| JUNB SRX10119385 | MCF 10A Breast | 176 / 21515 (0.8%) | 9715 / 215150 (4.5%) | −208.8 | −206.7 | 0.18 |
| STAT3 SRX150536 | MCF 10A Breast | 511 / 21515 (2.4%) | 15689 / 215150 (7.3%) | −208.3 | −206.2 | 0.33 |
| ARID1A SRX5679787 | 12Z Others | 149 / 21515 (0.7%) | 9116 / 215150 (4.2%) | −207.7 | −205.6 | 0.16 |
| ESR1 SRX330070 | MCF-7 Breast | 214 / 21515 (1.0%) | 10441 / 215150 (4.9%) | −207.5 | −205.4 | 0.20 |
| FOSL2 SRX5054308 | Neural progenitor cells Neural | 320 / 21515 (1.5%) | 12410 / 215150 (5.8%) | −207.2 | −205.1 | 0.26 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 612 / 21515 (2.8%) | 17248 / 215150 (8.0%) | −206.8 | −204.7 | 0.35 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 646 / 21515 (3.0%) | 1206 / 215150 (0.6%) | −206.7 | −204.6 | 5.36 |
| NFYB SRX16608147 | HeLa Uterus | 340 / 21515 (1.6%) | 210 / 215150 (0.1%) | −206.3 | −204.2 | 16.19 |
| NR1H3 SRX1538760 | HT-29 Digestive tract | 434 / 21515 (2.0%) | 14328 / 215150 (6.7%) | −205.5 | −203.4 | 0.30 |
| EP300 SRX10976625 | A549 Lung | 251 / 21515 (1.2%) | 11071 / 215150 (5.1%) | −204.8 | −202.7 | 0.23 |
| WWTR1 SRX10119368 | MCF 10A Breast | 308 / 21515 (1.4%) | 12107 / 215150 (5.6%) | −204.3 | −202.2 | 0.25 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 760 / 21515 (3.5%) | 1717 / 215150 (0.8%) | −204.2 | −202.1 | 4.43 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 633 / 21515 (2.9%) | 1171 / 215150 (0.5%) | −204.1 | −202.0 | 5.41 |
| ESR1 SRX1469949 | MCF-7 Breast | 247 / 21515 (1.1%) | 10958 / 215150 (5.1%) | −203.6 | −201.5 | 0.23 |
| FOXA1 SRX100454 | T-47D Breast | 621 / 21515 (2.9%) | 17274 / 215150 (8.0%) | −203.6 | −201.5 | 0.36 |
| ARID1A SRX5679788 | 12Z Others | 172 / 21515 (0.8%) | 9462 / 215150 (4.4%) | −202.9 | −200.8 | 0.18 |
| ESR1 SRX1012629 | MCF-7 Breast | 278 / 21515 (1.3%) | 11511 / 215150 (5.4%) | −202.7 | −200.6 | 0.24 |
| Epitope tags SRX11470532 | Mesenchymal stem cells Others | 624 / 21515 (2.9%) | 17285 / 215150 (8.0%) | −202.6 | −200.5 | 0.36 |
| FOXA1 SRX11222437 | MCF-7 Breast | 332 / 21515 (1.5%) | 12452 / 215150 (5.8%) | −201.7 | −199.6 | 0.27 |
| ESR1 SRX5323873 | MCF-7 Breast | 581 / 21515 (2.7%) | 16575 / 215150 (7.7%) | −201.5 | −199.5 | 0.35 |
| TEAD1 SRX716558 | SF268 Neural | 211 / 21515 (1.0%) | 10200 / 215150 (4.7%) | −201.4 | −199.3 | 0.21 |
| MITF SRX7368255 | Hermes 3C Epidermis | 1367 / 21515 (6.4%) | 27862 / 215150 (13.0%) | −201.1 | −199.1 | 0.49 |
| NKX2-1 SRX2164786 | A549 Lung | 801 / 21515 (3.7%) | 19893 / 215150 (9.2%) | −200.7 | −198.6 | 0.40 |
| NR3C1 SRX10977373 | A549 Lung | 238 / 21515 (1.1%) | 10700 / 215150 (5.0%) | −200.6 | −198.5 | 0.22 |
| EP300 ERX626821 | U-937 Blood | 1539 / 21515 (7.2%) | 6061 / 215150 (2.8%) | −200.6 | −198.5 | 2.54 |
| ESR1 SRX10365558 | MCF-7 Breast | 309 / 21515 (1.4%) | 11996 / 215150 (5.6%) | −200.3 | −198.2 | 0.26 |
| ESR1 SRX3123829 | MCF-7 Breast | 251 / 21515 (1.2%) | 10923 / 215150 (5.1%) | −200.0 | −197.9 | 0.23 |
| ARID1A SRX5089379 | MCF-7 Breast | 474 / 21515 (2.2%) | 14791 / 215150 (6.9%) | −199.6 | −197.5 | 0.32 |
| JUN SRX2355073 | HAEC Cardiovascular | 600 / 21515 (2.8%) | 16803 / 215150 (7.8%) | −199.5 | −197.5 | 0.36 |
| MLLT6 DRX059637 | 293 Kidney | 513 / 21515 (2.4%) | 743 / 215150 (0.3%) | −199.4 | −197.4 | 6.90 |
| FOXA1 SRX3923514 | MCF-7 Breast | 492 / 21515 (2.3%) | 15076 / 215150 (7.0%) | −199.4 | −197.3 | 0.33 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 448 / 21515 (2.1%) | 14353 / 215150 (6.7%) | −199.2 | −197.2 | 0.31 |
| FOS SRX3322636 | MCF-7 Breast | 296 / 21515 (1.4%) | 11730 / 215150 (5.5%) | −199.1 | −197.1 | 0.25 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 444 / 21515 (2.1%) | 14266 / 215150 (6.6%) | −198.6 | −196.6 | 0.31 |
| ESR1 SRX20282946 | MCF-7 Breast | 273 / 21515 (1.3%) | 11286 / 215150 (5.2%) | −198.4 | −196.4 | 0.24 |
| TP53 SRX19538269 | U2OS Bone | 458 / 21515 (2.1%) | 564 / 215150 (0.3%) | −198.1 | −196.0 | 8.12 |
| RELA SRX7055007 | HAEC Cardiovascular | 882 / 21515 (4.1%) | 20977 / 215150 (9.7%) | −197.9 | −195.9 | 0.42 |
| PROX1 SRX3230397 | Hep G2 Liver | 333 / 21515 (1.5%) | 12346 / 215150 (5.7%) | −197.8 | −195.8 | 0.27 |
| ARID5B SRX3230377 | Hep G2 Liver | 1208 / 21515 (5.6%) | 25554 / 215150 (11.9%) | −197.7 | −195.6 | 0.47 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 764 / 21515 (3.6%) | 1796 / 215150 (0.8%) | −197.1 | −195.1 | 4.25 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 980 / 21515 (4.6%) | 2871 / 215150 (1.3%) | −197.0 | −194.9 | 3.41 |
| FOXA1 SRX11222442 | MCF-7 Breast | 311 / 21515 (1.4%) | 11926 / 215150 (5.5%) | −196.8 | −194.7 | 0.26 |
| FOSL1 SRX2585779 | MDA-MB-231 Breast | 211 / 21515 (1.0%) | 10056 / 215150 (4.7%) | −196.4 | −194.4 | 0.21 |
| RELA SRX7054617 | HAEC Cardiovascular | 579 / 21515 (2.7%) | 16349 / 215150 (7.6%) | −196.0 | −194.0 | 0.35 |
| FOS SRX7760064 | CFPAC-1 Pancreas | 384 / 21515 (1.8%) | 13167 / 215150 (6.1%) | −195.9 | −193.8 | 0.29 |
| TP53 SRX19538270 | U2OS Bone | 447 / 21515 (2.1%) | 539 / 215150 (0.3%) | −195.8 | −193.8 | 8.29 |
| SMARCA4 SRX8588626 | Pulmonary artery endothelial cells Cardiovascular | 651 / 21515 (3.0%) | 17451 / 215150 (8.1%) | −195.6 | −193.5 | 0.37 |
| SMC1A SRX1013333 | HuCCT1 Liver | 938 / 21515 (4.4%) | 21691 / 215150 (10.1%) | −195.6 | −193.5 | 0.43 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 1600 / 21515 (7.4%) | 6539 / 215150 (3.0%) | −195.3 | −193.2 | 2.45 |
| ESR1 SRX1012632 | MCF-7 Breast | 220 / 21515 (1.0%) | 10189 / 215150 (4.7%) | −195.1 | −193.1 | 0.22 |
| FOXA1 SRX13814018 | 5637 Others | 284 / 21515 (1.3%) | 11373 / 215150 (5.3%) | −194.7 | −192.7 | 0.25 |
| RNF2 SRX18954719 | SCC-25 Others | 647 / 21515 (3.0%) | 17354 / 215150 (8.1%) | −194.6 | −192.6 | 0.37 |
| SMARCA4 SRX5982340 | A549 Lung | 173 / 21515 (0.8%) | 9243 / 215150 (4.3%) | −194.6 | −192.6 | 0.19 |
| FOXA1 SRX1161174 | MCF-7 Breast | 515 / 21515 (2.4%) | 15287 / 215150 (7.1%) | −194.6 | −192.5 | 0.34 |
| TEAD4 SRX10640862 | SK-MEL-147 Epidermis | 746 / 21515 (3.5%) | 18842 / 215150 (8.8%) | −194.4 | −192.4 | 0.40 |
| ESR1 SRX371477 | MCF-7 Breast | 234 / 21515 (1.1%) | 10432 / 215150 (4.8%) | −194.3 | −192.2 | 0.22 |
| FOXA2 SRX5504126 | CFPAC-1 Pancreas | 296 / 21515 (1.4%) | 11570 / 215150 (5.4%) | −194.1 | −192.1 | 0.26 |
| EP300 SRX176885 | MCF-7 Breast | 236 / 21515 (1.1%) | 10464 / 215150 (4.9%) | −194.1 | −192.1 | 0.23 |
| ESR1 SRX2943591 | MCF-7 Breast | 333 / 21515 (1.5%) | 12229 / 215150 (5.7%) | −194.0 | −192.0 | 0.27 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 447 / 21515 (2.1%) | 14159 / 215150 (6.6%) | −194.0 | −191.9 | 0.32 |
| NR3C1 SRX2609667 | HASM2 Lung | 473 / 21515 (2.2%) | 14581 / 215150 (6.8%) | −193.8 | −191.8 | 0.32 |
| TEAD4 SRX10640861 | SK-MEL-147 Epidermis | 514 / 21515 (2.4%) | 15243 / 215150 (7.1%) | −193.8 | −191.7 | 0.34 |
| ESR1 SRX371475 | BT-474 Breast | 234 / 21515 (1.1%) | 10413 / 215150 (4.8%) | −193.7 | −191.7 | 0.22 |
| ESR1 SRX2513517 | MCF-7 Breast | 316 / 21515 (1.5%) | 11910 / 215150 (5.5%) | −193.4 | −191.4 | 0.27 |
| DDIT3 SRX11379509 | Liposarcoma, Myxoid Adipocyte | 354 / 21515 (1.6%) | 12566 / 215150 (5.8%) | −193.3 | −191.3 | 0.28 |
| ESR1 SRX371474 | BT-474 Breast | 210 / 21515 (1.0%) | 9928 / 215150 (4.6%) | −192.9 | −190.8 | 0.21 |
| ATF1 SRX11470450 | Mesenchymal stem cells Others | 942 / 21515 (4.4%) | 21640 / 215150 (10.1%) | −192.9 | −190.8 | 0.44 |
| FOXA1 SRX028634 | MCF-7 Breast | 227 / 21515 (1.1%) | 10250 / 215150 (4.8%) | −192.6 | −190.6 | 0.22 |
| ESR1 SRX1469951 | MCF-7 Breast | 235 / 21515 (1.1%) | 10398 / 215150 (4.8%) | −192.5 | −190.5 | 0.23 |
| RELA SRX7054663 | HAEC Cardiovascular | 408 / 21515 (1.9%) | 13463 / 215150 (6.3%) | −192.4 | −190.4 | 0.30 |
| RELA SRX7054657 | HAEC Cardiovascular | 550 / 21515 (2.6%) | 15767 / 215150 (7.3%) | −192.4 | −190.4 | 0.35 |
| FOXA1 SRX1787651 | MCF-7 Breast | 262 / 21515 (1.2%) | 10897 / 215150 (5.1%) | −192.3 | −190.3 | 0.24 |
| TLE3 SRX4815192 | MCF-7 Breast | 441 / 21515 (2.0%) | 14004 / 215150 (6.5%) | −192.3 | −190.3 | 0.31 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 496 / 21515 (2.3%) | 14895 / 215150 (6.9%) | −192.1 | −190.1 | 0.33 |
| ESR1 SRX1012633 | MCF-7 Breast | 235 / 21515 (1.1%) | 10385 / 215150 (4.8%) | −192.1 | −190.1 | 0.23 |
| EP300 SRX100540 | SK-N-SH Neural | 709 / 21515 (3.3%) | 18192 / 215150 (8.5%) | −191.9 | −189.9 | 0.39 |
| NKX2-1 SRX366169 | NCI-H441 Lung | 588 / 21515 (2.7%) | 16342 / 215150 (7.6%) | −191.9 | −189.9 | 0.36 |
| ESR1 SRX1995229 | MCF-7 Breast | 479 / 21515 (2.2%) | 14608 / 215150 (6.8%) | −191.8 | −189.8 | 0.33 |
| MAU2 SRX15710569 | RPE Neural | 453 / 21515 (2.1%) | 14186 / 215150 (6.6%) | −191.7 | −189.8 | 0.32 |
| FOXA1 SRX11222441 | MCF-7 Breast | 375 / 21515 (1.7%) | 12861 / 215150 (6.0%) | −191.2 | −189.2 | 0.29 |
| JUNB SRX2443774 | A549 Lung | 191 / 21515 (0.9%) | 9504 / 215150 (4.4%) | −191.0 | −189.0 | 0.20 |
| NFIC SRX190336 | SK-N-SH Neural | 686 / 21515 (3.2%) | 17817 / 215150 (8.3%) | −191.0 | −189.0 | 0.39 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 346 / 21515 (1.6%) | 12354 / 215150 (5.7%) | −190.8 | −188.9 | 0.28 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 392 / 21515 (1.8%) | 13137 / 215150 (6.1%) | −190.8 | −188.8 | 0.30 |
| ESR1 SRX5323872 | MCF-7 Breast | 487 / 21515 (2.3%) | 14693 / 215150 (6.8%) | −190.5 | −188.5 | 0.33 |
| FOXA1 SRX1787653 | MCF-7 Breast | 405 / 21515 (1.9%) | 13345 / 215150 (6.2%) | −190.4 | −188.4 | 0.30 |
| ESR1 SRX5323871 | MCF-7 Breast | 533 / 21515 (2.5%) | 15424 / 215150 (7.2%) | −190.3 | −188.3 | 0.35 |
| NANOG SRX20532160 | hESC HUES8 Pluripotent stem cell | 1457 / 21515 (6.8%) | 28576 / 215150 (13.3%) | −189.9 | −187.9 | 0.51 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 457 / 21515 (2.1%) | 14172 / 215150 (6.6%) | −189.5 | −187.5 | 0.32 |
| HMG20A SRX2630163 | Hep G2 Liver | 263 / 21515 (1.2%) | 10827 / 215150 (5.0%) | −189.4 | −187.4 | 0.24 |
| EP300 ERX626811 | U-937 Blood | 1512 / 21515 (7.0%) | 6085 / 215150 (2.8%) | −189.4 | −187.4 | 2.48 |
| TEAD1 SRX1011298 | HuCCT1 Liver | 184 / 21515 (0.9%) | 9316 / 215150 (4.3%) | −189.3 | −187.4 | 0.20 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 536 / 21515 (2.5%) | 15435 / 215150 (7.2%) | −189.3 | −187.3 | 0.35 |
| ESR1 SRX8537722 | MCF-7 Breast | 453 / 21515 (2.1%) | 14090 / 215150 (6.5%) | −189.0 | −187.0 | 0.32 |
| FOXA1 SRX5323843 | MCF-7 Breast | 240 / 21515 (1.1%) | 10386 / 215150 (4.8%) | −188.9 | −186.9 | 0.23 |
| EP300 SRX190219 | SK-N-SH Neural | 479 / 21515 (2.2%) | 14486 / 215150 (6.7%) | −188.2 | −186.2 | 0.33 |
| TEAD1 SRX7807114 | Unclassified Unclassified | 240 / 21515 (1.1%) | 10360 / 215150 (4.8%) | −188.2 | −186.2 | 0.23 |
| TEAD1 SRX3401272 | MCF-7 Breast | 371 / 21515 (1.7%) | 12683 / 215150 (5.9%) | −187.8 | −185.8 | 0.29 |
| ESR1 SRX1531796 | MCF-7 Breast | 250 / 21515 (1.2%) | 10534 / 215150 (4.9%) | −187.7 | −185.7 | 0.24 |
| KAT7 DRX300414 | 293 Kidney | 781 / 21515 (3.6%) | 1963 / 215150 (0.9%) | −187.7 | −185.7 | 3.98 |
| NR3C1 SRX2609668 | HASM2 Lung | 368 / 21515 (1.7%) | 12620 / 215150 (5.9%) | −187.4 | −185.5 | 0.29 |
| ESR1 SRX330068 | MCF-7 Breast | 217 / 21515 (1.0%) | 9906 / 215150 (4.6%) | −187.4 | −185.5 | 0.22 |
| TLE3 SRX4815193 | SUM 149PT Breast | 494 / 21515 (2.3%) | 14694 / 215150 (6.8%) | −187.2 | −185.3 | 0.34 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 232 / 21515 (1.1%) | 10177 / 215150 (4.7%) | −187.0 | −185.1 | 0.23 |
| FOXA1 SRX190181 | A549 Lung | 351 / 21515 (1.6%) | 12311 / 215150 (5.7%) | −186.9 | −185.0 | 0.29 |
| PGR SRX1012655 | MCF-7 Breast | 308 / 21515 (1.4%) | 11557 / 215150 (5.4%) | −186.8 | −184.9 | 0.27 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 231 / 21515 (1.1%) | 10145 / 215150 (4.7%) | −186.7 | −184.7 | 0.23 |
| TAL1 SRX393516 | Primary endothelial cells Cardiovascular | 603 / 21515 (2.8%) | 16388 / 215150 (7.6%) | −186.6 | −184.7 | 0.37 |
| Epitope tags SRX10549778 | K-562 Blood | 1352 / 21515 (6.3%) | 5139 / 215150 (2.4%) | −186.5 | −184.6 | 2.63 |
| FOXA1 SRX5203303 | MCF-7 Breast | 150 / 21515 (0.7%) | 8541 / 215150 (4.0%) | −186.5 | −184.6 | 0.18 |
| SMAD3 SRX11483609 | Keratinocytes Epidermis | 710 / 21515 (3.3%) | 18003 / 215150 (8.4%) | −186.3 | −184.4 | 0.39 |
| RNF2 SRX18954704 | FaDu Others | 1179 / 21515 (5.5%) | 24685 / 215150 (11.5%) | −186.3 | −184.4 | 0.48 |
| FOS SRX3322637 | MCF-7 Breast | 252 / 21515 (1.2%) | 10524 / 215150 (4.9%) | −186.2 | −184.2 | 0.24 |
| FOXA2 SRX100448 | Hep G2 Liver | 557 / 21515 (2.6%) | 15653 / 215150 (7.3%) | −186.1 | −184.1 | 0.36 |
| FOXL2 SRX6957431 | KGN Gonad | 1147 / 21515 (5.3%) | 24233 / 215150 (11.3%) | −186.1 | −184.1 | 0.47 |
| 8-Hydroxydeoxyguanosine SRX6895233 | MCF 10A Breast | 1048 / 21515 (4.9%) | 3377 / 215150 (1.6%) | −185.6 | −183.7 | 3.10 |
| ESR1 SRX2912055 | MCF-7 Breast | 176 / 21515 (0.8%) | 9047 / 215150 (4.2%) | −185.6 | −183.7 | 0.19 |
| NANOG SRX20532161 | hESC HUES8 Pluripotent stem cell | 1308 / 21515 (6.1%) | 26399 / 215150 (12.3%) | −185.6 | −183.6 | 0.50 |
| FOXA1 SRX1787655 | MCF-7 Breast | 240 / 21515 (1.1%) | 10273 / 215150 (4.8%) | −185.3 | −183.4 | 0.23 |
| ARID1A SRX5089385 | MCF-7 Breast | 367 / 21515 (1.7%) | 12529 / 215150 (5.8%) | −185.2 | −183.3 | 0.29 |
| Epitope tags SRX2745846 | MCF 10A Breast | 315 / 21515 (1.5%) | 11617 / 215150 (5.4%) | −184.7 | −182.8 | 0.27 |
| STAT5B SRX831881 | CD8+ T cells Blood | 291 / 21515 (1.4%) | 160 / 215150 (0.1%) | −184.4 | −182.4 | 18.19 |
| STAT1 SRX23678708 | K-562 Blood | 1858 / 21515 (8.6%) | 8455 / 215150 (3.9%) | −184.1 | −182.1 | 2.20 |
| FOXA1 SRX100506 | Hep G2 Liver | 680 / 21515 (3.2%) | 17462 / 215150 (8.1%) | −183.9 | −182.0 | 0.39 |
| NR3C1 SRX18884271 | A549 Lung | 253 / 21515 (1.2%) | 10463 / 215150 (4.9%) | −183.6 | −181.6 | 0.24 |
| FOSL1 SRX17608312 | T24 Others | 174 / 21515 (0.8%) | 8946 / 215150 (4.2%) | −183.5 | −181.6 | 0.19 |
| GFP SRX6949256 | HeLa Uterus | 545 / 21515 (2.5%) | 15376 / 215150 (7.1%) | −183.5 | −181.6 | 0.35 |
| CEBPB SRX11379527 | Liposarcoma, Myxoid Adipocyte | 893 / 21515 (4.2%) | 20559 / 215150 (9.6%) | −183.2 | −181.3 | 0.43 |
| GATA2 SRX3503584 | Endometrial stromal cells Uterus | 560 / 21515 (2.6%) | 15591 / 215150 (7.2%) | −183.0 | −181.1 | 0.36 |
| Epitope tags SRX5877912 | U2OS Bone | 2755 / 21515 (12.8%) | 44498 / 215150 (20.7%) | −183.0 | −181.0 | 0.62 |
| ESR1 SRX2513520 | MCF-7 Breast | 306 / 21515 (1.4%) | 11389 / 215150 (5.3%) | −182.6 | −180.6 | 0.27 |
| EP300 SRX1012648 | MCF-7 Breast | 228 / 21515 (1.1%) | 9966 / 215150 (4.6%) | −182.5 | −180.6 | 0.23 |
| 8-Hydroxydeoxyguanosine SRX6895232 | MCF 10A Breast | 1103 / 21515 (5.1%) | 3732 / 215150 (1.7%) | −182.2 | −180.3 | 2.96 |
| STAT3 SRX4192888 | MCF 10A Breast | 236 / 21515 (1.1%) | 10098 / 215150 (4.7%) | −181.9 | −179.9 | 0.23 |
| MITF SRX7368256 | Hermes 3C Epidermis | 981 / 21515 (4.6%) | 21755 / 215150 (10.1%) | −181.9 | −179.9 | 0.45 |
| WWTR1 SRX10119390 | MDA-MB-231 Breast | 166 / 21515 (0.8%) | 8730 / 215150 (4.1%) | −181.7 | −179.8 | 0.19 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 481 / 21515 (2.2%) | 14295 / 215150 (6.6%) | −181.6 | −179.7 | 0.34 |
| ESR1 SRX2943589 | MCF-7 Breast | 248 / 21515 (1.2%) | 10298 / 215150 (4.8%) | −181.3 | −179.3 | 0.24 |
| ESR1 SRX3110723 | MCF-7 Breast | 268 / 21515 (1.2%) | 10646 / 215150 (4.9%) | −180.6 | −178.7 | 0.25 |
| RAD21 SRX150650 | HeLa Uterus | 682 / 21515 (3.2%) | 17365 / 215150 (8.1%) | −180.5 | −178.6 | 0.39 |
| NR1H3 SRX1538763 | HT-29 Digestive tract | 477 / 21515 (2.2%) | 14189 / 215150 (6.6%) | −180.4 | −178.5 | 0.34 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 511 / 21515 (2.4%) | 845 / 215150 (0.4%) | −180.2 | −178.3 | 6.05 |
| SMARCA4 SRX8588625 | Pulmonary artery endothelial cells Cardiovascular | 534 / 21515 (2.5%) | 15085 / 215150 (7.0%) | −180.2 | −178.3 | 0.35 |
| SMARCA4 SRX5982341 | A549 Lung | 139 / 21515 (0.6%) | 8126 / 215150 (3.8%) | −180.1 | −178.2 | 0.17 |
| ESR1 SRX10365533 | MCF-7 Breast | 236 / 21515 (1.1%) | 10028 / 215150 (4.7%) | −179.6 | −177.7 | 0.24 |
| GATAD2A SRX2636506 | Hep G2 Liver | 654 / 21515 (3.0%) | 16909 / 215150 (7.9%) | −179.6 | −177.7 | 0.39 |
| FOS SRX7760063 | CFPAC-1 Pancreas | 313 / 21515 (1.5%) | 11413 / 215150 (5.3%) | −179.5 | −177.6 | 0.27 |
| SOX13 SRX2636248 | Hep G2 Liver | 706 / 21515 (3.3%) | 17679 / 215150 (8.2%) | −179.3 | −177.3 | 0.40 |
| FOXA1 SRX5203294 | MCF-7 Breast | 130 / 21515 (0.6%) | 7914 / 215150 (3.7%) | −179.2 | −177.3 | 0.16 |
| ESR1 SRX5323878 | MCF-7 Breast | 510 / 21515 (2.4%) | 14672 / 215150 (6.8%) | −179.2 | −177.2 | 0.35 |
| ESR1 SRX2513521 | MCF-7 Breast | 229 / 21515 (1.1%) | 9881 / 215150 (4.6%) | −179.1 | −177.2 | 0.23 |
| FOXA1 SRX5203307 | MCF-7 Breast | 134 / 21515 (0.6%) | 7986 / 215150 (3.7%) | −178.8 | −176.9 | 0.17 |
| FOXA1 SRX100477 | Hep G2 Liver | 591 / 21515 (2.7%) | 15903 / 215150 (7.4%) | −178.3 | −176.4 | 0.37 |
| JUN SRX150358 | HUVEC Cardiovascular | 325 / 21515 (1.5%) | 11582 / 215150 (5.4%) | −178.2 | −176.3 | 0.28 |
| FOXA1 SRX3923516 | MCF-7 Breast | 369 / 21515 (1.7%) | 12333 / 215150 (5.7%) | −178.2 | −176.3 | 0.30 |
| SMARCC1 SRX11379526 | Liposarcoma, Myxoid Adipocyte | 396 / 21515 (1.8%) | 12786 / 215150 (5.9%) | −178.2 | −176.3 | 0.31 |
| ESR1 SRX1995230 | MCF-7 Breast | 424 / 21515 (2.0%) | 13243 / 215150 (6.2%) | −178.0 | −176.1 | 0.32 |
| FOXA1 SRX028635 | MCF-7 Breast | 248 / 21515 (1.2%) | 10201 / 215150 (4.7%) | −178.0 | −176.1 | 0.24 |
| MCM7 SRX8970972 | Squamous cell carcinoma Others | 579 / 21515 (2.7%) | 15705 / 215150 (7.3%) | −177.9 | −176.0 | 0.37 |
| CEBPA SRX2630241 | Hep G2 Liver | 629 / 21515 (2.9%) | 16468 / 215150 (7.7%) | −177.9 | −176.0 | 0.38 |
| Epitope tags SRX11470534 | Mesenchymal stem cells Others | 930 / 21515 (4.3%) | 20874 / 215150 (9.7%) | −177.8 | −175.9 | 0.45 |
| SMARCA4 SRX5982364 | A549 Lung | 148 / 21515 (0.7%) | 8250 / 215150 (3.8%) | −177.8 | −175.9 | 0.18 |
| KMT2D SRX15826241 | MDA-MB-231 Breast | 154 / 21515 (0.7%) | 8374 / 215150 (3.9%) | −177.8 | −175.9 | 0.18 |
| ESR1 SRX8537723 | MCF-7 Breast | 410 / 21515 (1.9%) | 13001 / 215150 (6.0%) | −177.7 | −175.8 | 0.32 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 471 / 21515 (2.2%) | 13995 / 215150 (6.5%) | −177.7 | −175.8 | 0.34 |
| BRD4 SRX736204 | 90-8TL Neural | 1068 / 21515 (5.0%) | 3596 / 215150 (1.7%) | −177.5 | −175.6 | 2.97 |
| TEAD4 SRX10640860 | SK-MEL-147 Epidermis | 719 / 21515 (3.3%) | 17796 / 215150 (8.3%) | −177.2 | −175.3 | 0.40 |
| TP53 SRX396254 | Fibroblasts Others | 1032 / 21515 (4.8%) | 3397 / 215150 (1.6%) | −177.2 | −175.3 | 3.04 |
| EP300 SRX1012644 | MCF-7 Breast | 222 / 21515 (1.0%) | 9690 / 215150 (4.5%) | −177.2 | −175.3 | 0.23 |
| ZEB1 SRX13298925 | MCF-7 Breast | 310 / 21515 (1.4%) | 11287 / 215150 (5.2%) | −177.2 | −175.3 | 0.27 |
| 8-Hydroxydeoxyguanosine SRX6895234 | MCF 10A Breast | 1010 / 21515 (4.7%) | 3276 / 215150 (1.5%) | −177.1 | −175.2 | 3.08 |
| JUNB SRX4677294 | CFPAC-1 Pancreas | 323 / 21515 (1.5%) | 11502 / 215150 (5.3%) | −176.9 | −175.0 | 0.28 |
| GFP SRX5417098 | HeLa Uterus | 595 / 21515 (2.8%) | 15908 / 215150 (7.4%) | −176.7 | −174.9 | 0.37 |
| CREBBP SRX7214025 | Keratinocytes Epidermis | 300 / 21515 (1.4%) | 11092 / 215150 (5.2%) | −176.6 | −174.8 | 0.27 |
| TCF21 DRX190655 | HCF Cardiovascular | 846 / 21515 (3.9%) | 19625 / 215150 (9.1%) | −176.6 | −174.7 | 0.43 |
| RNF2 SRX18954702 | FaDu Others | 1147 / 21515 (5.3%) | 23832 / 215150 (11.1%) | −176.5 | −174.6 | 0.48 |
| NR3C1 SRX10976922 | A549 Lung | 203 / 21515 (0.9%) | 9307 / 215150 (4.3%) | −176.4 | −174.6 | 0.22 |
| NR3C1 SRX10976392 | A549 Lung | 222 / 21515 (1.0%) | 9668 / 215150 (4.5%) | −176.4 | −174.5 | 0.23 |
| NR3C1 SRX10977364 | A549 Lung | 218 / 21515 (1.0%) | 9581 / 215150 (4.5%) | −176.0 | −174.1 | 0.23 |
| CEBPB SRX1027438 | Mesenchymal stem cells Others | 658 / 21515 (3.1%) | 16831 / 215150 (7.8%) | −175.8 | −173.9 | 0.39 |
| FOXA2 SRX3230382 | Hep G2 Liver | 712 / 21515 (3.3%) | 17634 / 215150 (8.2%) | −175.7 | −173.8 | 0.40 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 1122 / 21515 (5.2%) | 23453 / 215150 (10.9%) | −175.6 | −173.7 | 0.48 |
| ESR1 SRX5534832 | MCF-7 Breast | 467 / 21515 (2.2%) | 13852 / 215150 (6.4%) | −175.4 | −173.5 | 0.34 |
| MLXIP SRX5391034 | Skeletal myotubes Muscle | 627 / 21515 (2.9%) | 16348 / 215150 (7.6%) | −175.4 | −173.5 | 0.38 |
| SMARCA2 SRX5982361 | A549 Lung | 153 / 21515 (0.7%) | 8281 / 215150 (3.8%) | −175.3 | −173.4 | 0.18 |
| FOXA1 SRX1787652 | MCF-7 Breast | 315 / 21515 (1.5%) | 11304 / 215150 (5.3%) | −175.1 | −173.2 | 0.28 |
| 8-Hydroxydeoxyguanosine SRX2935292 | MCF 10A Breast | 2004 / 21515 (9.3%) | 9661 / 215150 (4.5%) | −175.1 | −173.2 | 2.07 |
| RNF2 SRX18954706 | SCC-25 Others | 631 / 21515 (2.9%) | 16381 / 215150 (7.6%) | −174.6 | −172.8 | 0.39 |
| ESR1 SRX20282959 | MCF-7 Breast | 210 / 21515 (1.0%) | 9386 / 215150 (4.4%) | −174.6 | −172.7 | 0.22 |
| ESR1 SRX2881001 | MCF-7 Breast | 276 / 21515 (1.3%) | 10603 / 215150 (4.9%) | −174.6 | −172.7 | 0.26 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 859 / 21515 (4.0%) | 19728 / 215150 (9.2%) | −174.5 | −172.7 | 0.44 |
| RELA SRX7054618 | HAEC Cardiovascular | 510 / 21515 (2.4%) | 14507 / 215150 (6.7%) | −174.5 | −172.6 | 0.35 |
| ARID1A SRX5089388 | MCF-7 Breast | 257 / 21515 (1.2%) | 10254 / 215150 (4.8%) | −174.4 | −172.6 | 0.25 |
| ESR1 SRX1012625 | MCF-7 Breast | 267 / 21515 (1.2%) | 10434 / 215150 (4.8%) | −174.4 | −172.5 | 0.26 |
| FOSL1 SRX190212 | HCT 116 Digestive tract | 602 / 21515 (2.8%) | 15929 / 215150 (7.4%) | −174.3 | −172.5 | 0.38 |
| TP53 SRX19538282 | Osteoblasts Bone | 376 / 21515 (1.7%) | 412 / 215150 (0.2%) | −174.3 | −172.4 | 9.13 |
| RELA SRX7054609 | HAEC Cardiovascular | 420 / 21515 (2.0%) | 13044 / 215150 (6.1%) | −174.1 | −172.2 | 0.32 |
| Epitope tags SRX11470445 | Mesenchymal stem cells Others | 661 / 21515 (3.1%) | 16809 / 215150 (7.8%) | −174.0 | −172.2 | 0.39 |
| AGO2 SRX6783957 | Hep G2 Liver | 1411 / 21515 (6.6%) | 5721 / 215150 (2.7%) | −174.0 | −172.1 | 2.47 |
| FOXA1 SRX3923517 | MCF-7 Breast | 371 / 21515 (1.7%) | 12227 / 215150 (5.7%) | −173.9 | −172.1 | 0.30 |
| FOXA2 SRX6441751 | CFPAC-1 Pancreas | 228 / 21515 (1.1%) | 9699 / 215150 (4.5%) | −173.8 | −172.0 | 0.24 |
| ESR1 SRX176856 | MCF-7 Breast | 164 / 21515 (0.8%) | 8453 / 215150 (3.9%) | −173.4 | −171.5 | 0.19 |
| HOXC5 SRX2731653 | PC-3 Prostate | 411 / 21515 (1.9%) | 12869 / 215150 (6.0%) | −173.3 | −171.4 | 0.32 |
| JUN SRX883585 | MDA-MB-231 Breast | 610 / 21515 (2.8%) | 16008 / 215150 (7.4%) | −173.3 | −171.4 | 0.38 |
| FOXA1 SRX5323845 | MCF-7 Breast | 179 / 21515 (0.8%) | 8743 / 215150 (4.1%) | −173.2 | −171.4 | 0.20 |
| KMT2A SRX5732680 | MOLM-13 Blood | 1621 / 21515 (7.5%) | 7102 / 215150 (3.3%) | −172.7 | −170.8 | 2.28 |
| ESR1 SRX5323877 | MCF-7 Breast | 403 / 21515 (1.9%) | 12712 / 215150 (5.9%) | −172.5 | −170.6 | 0.32 |
| GATAD2A SRX2636507 | Hep G2 Liver | 563 / 21515 (2.6%) | 15253 / 215150 (7.1%) | −172.3 | −170.5 | 0.37 |
| ESR1 SRX1012630 | MCF-7 Breast | 192 / 21515 (0.9%) | 8962 / 215150 (4.2%) | −172.0 | −170.2 | 0.21 |
| ZEB1 SRX13298923 | MCF-7 Breast | 210 / 21515 (1.0%) | 9307 / 215150 (4.3%) | −172.0 | −170.2 | 0.23 |
| BRD4 SRX612504 | LX2 Liver | 241 / 21515 (1.1%) | 9880 / 215150 (4.6%) | −171.8 | −170.0 | 0.24 |
| YAP1 SRX10119363 | MCF 10A Breast | 215 / 21515 (1.0%) | 9393 / 215150 (4.4%) | −171.8 | −169.9 | 0.23 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 351 / 21515 (1.6%) | 11810 / 215150 (5.5%) | −171.6 | −169.7 | 0.30 |
| FOXA1 SRX15430999 | T-47D Breast | 584 / 21515 (2.7%) | 15551 / 215150 (7.2%) | −171.6 | −169.7 | 0.38 |
| FOSL2 SRX10475405 | A549 Lung | 201 / 21515 (0.9%) | 9113 / 215150 (4.2%) | −171.3 | −169.5 | 0.22 |
| FOXA1 SRX11222438 | MCF-7 Breast | 279 / 21515 (1.3%) | 10543 / 215150 (4.9%) | −171.1 | −169.2 | 0.26 |
| DOT1L DRX411731 | 293 Kidney | 356 / 21515 (1.7%) | 366 / 215150 (0.2%) | −171.0 | −169.2 | 9.73 |
| NR3C1 SRX8520802 | HCC1187 Breast | 390 / 21515 (1.8%) | 12445 / 215150 (5.8%) | −170.9 | −169.1 | 0.31 |
| STAT1 SRX23678707 | K-562 Blood | 1705 / 21515 (7.9%) | 7707 / 215150 (3.6%) | −170.7 | −168.8 | 2.21 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 631 / 21515 (2.9%) | 1414 / 215150 (0.7%) | −170.7 | −168.8 | 4.46 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 351 / 21515 (1.6%) | 11776 / 215150 (5.5%) | −170.6 | −168.8 | 0.30 |
| NR3C1 SRX10976920 | A549 Lung | 180 / 21515 (0.8%) | 8684 / 215150 (4.0%) | −170.5 | −168.7 | 0.21 |
| DNA-RNA hybrid SRX20083261 | SH-SY5Y Neural | 695 / 21515 (3.2%) | 1713 / 215150 (0.8%) | −170.4 | −168.6 | 4.06 |
| FOXA1 SRX3923518 | MCF-7 Breast | 363 / 21515 (1.7%) | 11974 / 215150 (5.6%) | −170.4 | −168.5 | 0.30 |
| MYC SRX13134693 | 293 Kidney | 1570 / 21515 (7.3%) | 6815 / 215150 (3.2%) | −170.3 | −168.5 | 2.30 |
| NR3C1 SRX18884260 | A549 Lung | 300 / 21515 (1.4%) | 10892 / 215150 (5.1%) | −170.3 | −168.4 | 0.28 |
| ZEB1 SRX13298924 | MCF-7 Breast | 245 / 21515 (1.1%) | 9887 / 215150 (4.6%) | −169.6 | −167.8 | 0.25 |
| ESR1 SRX2513518 | MCF-7 Breast | 251 / 21515 (1.2%) | 9990 / 215150 (4.6%) | −169.5 | −167.7 | 0.25 |
| RELA SRX2207671 | HUVEC Cardiovascular | 274 / 21515 (1.3%) | 10404 / 215150 (4.8%) | −169.4 | −167.6 | 0.26 |
| SFPQ SRX593748 | MCF-7 Breast | 3440 / 21515 (16.0%) | 20639 / 215150 (9.6%) | −169.1 | −167.2 | 1.67 |
| SMARCA4 SRX8566546 | 786-O Kidney | 1767 / 21515 (8.2%) | 31629 / 215150 (14.7%) | −168.9 | −167.1 | 0.56 |
| FOXA1 SRX190282 | A549 Lung | 372 / 21515 (1.7%) | 12076 / 215150 (5.6%) | −168.9 | −167.0 | 0.31 |
| SMARCA4 SRX15419260 | 786-O Kidney | 1766 / 21515 (8.2%) | 31611 / 215150 (14.7%) | −168.8 | −167.0 | 0.56 |
| SMARCC1 SRX11379524 | Liposarcoma, Myxoid Adipocyte | 360 / 21515 (1.7%) | 11869 / 215150 (5.5%) | −168.8 | −167.0 | 0.30 |
| FOXA1 SRX3923515 | MCF-7 Breast | 293 / 21515 (1.4%) | 10716 / 215150 (5.0%) | −168.8 | −166.9 | 0.27 |
| EP300 SRX176883 | MCF-7 Breast | 243 / 21515 (1.1%) | 9810 / 215150 (4.6%) | −168.4 | −166.6 | 0.25 |
| FOXA1 SRX1389379 | CFPAC-1 Pancreas | 358 / 21515 (1.7%) | 11822 / 215150 (5.5%) | −168.4 | −166.6 | 0.30 |
| JUN SRX150421 | HeLa Uterus | 186 / 21515 (0.9%) | 8737 / 215150 (4.1%) | −168.4 | −166.6 | 0.21 |
| SMARCA4 SRX5716469 | Neural progenitor cells Neural | 363 / 21515 (1.7%) | 11897 / 215150 (5.5%) | −168.1 | −166.3 | 0.31 |
| FOXA1 SRX1447317 | MCF-7 Breast | 346 / 21515 (1.6%) | 11607 / 215150 (5.4%) | −167.9 | −166.1 | 0.30 |
| YAP1 SRX1038944 | IMR-90 Lung | 199 / 21515 (0.9%) | 8964 / 215150 (4.2%) | −167.6 | −165.8 | 0.22 |
Showing first 500 of 20969 rows.